Cargando…
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
BACKGROUND: The treatment of metastatic osteosarcoma (OS) remains a challenge for oncologists, and novel therapeutic strategies are urgently needed. An understanding of the pathways that regulate OS dissemination is required for the design of novel treatment approaches. We recently identified Rho-as...
Autores principales: | Zucchini, Cinzia, Manara, Maria Cristina, Cristalli, Camilla, Carrabotta, Marianna, Greco, Sara, Pinca, Rosa Simona, Ferrari, Cristina, Landuzzi, Lorena, Pasello, Michela, Lollini, Pier-Luigi, Gambarotti, Marco, Donati, Davide Maria, Scotlandi, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933701/ https://www.ncbi.nlm.nih.gov/pubmed/31878963 http://dx.doi.org/10.1186/s13046-019-1506-3 |
Ejemplares similares
-
Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017) -
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021) -
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019) -
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023) -
A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response
por: Pellegrini, Evelin, et al.
Publicado: (2022)